Chairman of the Board and CEO of BioScrip Inc. (BIOS, Financial) Richard H Friedman sells 36,900 shares of BIOS on 08/17/2009 at an average price of $5.81 a share.
BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors pharmaceutical manufacturers government agencies physicians and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: specialty medication distribution and clinical management services both nationally and community-based and pharmacy benefit management services. Bioscrip Inc. has a market cap of $246.5 million; its shares were traded at around $5.89 with a P/E ratio of 17.3 and P/S ratio of 0.2.
BIOS is in the portfolios of Arnold Van Den Berg of Century Management.
Recent Trades of BioScrip Inc. by Directors and Officers:
BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors pharmaceutical manufacturers government agencies physicians and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: specialty medication distribution and clinical management services both nationally and community-based and pharmacy benefit management services. Bioscrip Inc. has a market cap of $246.5 million; its shares were traded at around $5.89 with a P/E ratio of 17.3 and P/S ratio of 0.2.
BIOS is in the portfolios of Arnold Van Den Berg of Century Management.
Recent Trades of BioScrip Inc. by Directors and Officers:
- Buy: 10% Owner William J Nasgovitz bought 97,500 shares of BIOS stock on 04/30/2009 at the average price of $3.14; the price of the stock has increased by 87.58% since.
- Buy: 10% Owner William J Nasgovitz bought 20,000 more shares of BIOS stock on 04/08/2009 at the average price of $2.1; the price of the stock has increased by 180.48% since.
- Sell: Executive Vice President Scott Friedman sold 21,096 shares of BIOS stock on 08/11/2009 at the average price of $5.9; the price of the stock has decreased by 0.17% since.
- Sell: Executive Vice President Scott Friedman sold 3,904 more shares of BIOS stock on 08/06/2009 at the average price of $6.05; the price of the stock has decreased by 2.64% since.
- Sell: Executive Vice President Barry A Posner sold 50,000 shares of BIOS stock on 08/04/2009 at the average price of $6.24; the price of the stock has decreased by 5.61% since.
